Stock Market Impact: FTSE 100 fell 1.4% on Tuesday; Germany’s DAX dropped 0.8% while France’s CAC 40 rose 0.1%. Sterling strengthened 0.4% to $1.3385.
Listed Companies and Sectors: GlaxoSmithKline announced a $10.6 bn all‑cash acquisition of U.S. cancer‑drug developer Nuvalent at $124 per share, a 40% premium to the last closing price. Homebuilder MJ Gleeson projected adjusted pretax profit below market expectations after a construction slowdown delayed a site sale representing roughly half its forecast plot sales. Bellway reported cooling customer demand after a strong spring start, with rising fuel and energy costs pressuring margins. BP investors remained uncertain about the circumstances surrounding the ousting of former chair Albert Manifold in May.
Regulatory / Fiscal Actions: UK Foreign Secretary Yvette Cooper announced coordinated sanctions on six entities and one individual linked to financing settlement violence, and for the first time issued official guidance advising businesses against economic activity in illegal Israeli settlements. She also pledged £10 million in financial assistance to the Palestinian Authority for 2026 and an additional £1 million for humanitarian de‑mining in Gaza.
Relevance: Economic/Market-related
Potential Market Impact: Negative – immediate/short‑term pressure on UK equities; Positive – long‑term strategic boost for GSK’s oncology pipeline; Medium – sanctions and aid may affect sectoral flows over the medium term.
